Schroder Investment Management Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-52,076
| Closed | -$1.07M | – | 1264 |
|
|
2023
Q3 | $1.07M | Sell |
52,076
-98,228
| -65% | -$2.02M | ﹤0.01% | 1008 |
|
|
2023
Q2 | $7.07M | Buy |
150,304
+96,378
| +179% | +$4.53M | 0.01% | 711 |
|
|
2023
Q1 | $2.26M | Sell |
53,926
-3,460
| -6% | -$145K | ﹤0.01% | 932 |
|
|
2022
Q4 | $2.19M | Buy |
+57,386
| New | +$2.19M | ﹤0.01% | 928 |
|
|
2022
Q1 | – | Sell |
-143
| Closed | -$6K | – | 1554 |
|
|
2021
Q4 | $6K | Buy |
143
+59
| +70% | +$2.48K | ﹤0.01% | 1395 |
|
|
2021
Q3 | $4K | Hold |
84
| – | – | ﹤0.01% | 1476 |
|
|
2021
Q2 | $5K | Sell |
84
-30,315
| -100% | -$1.8M | ﹤0.01% | 1498 |
|
|
2021
Q1 | $2.28M | Sell |
30,399
-51,016
| -63% | -$3.82M | ﹤0.01% | 987 |
|
|
2020
Q4 | $7.04M | Buy |
81,415
+6,251
| +8% | +$541K | 0.01% | 725 |
|
|
2020
Q3 | $4.39M | Buy |
75,164
+14,611
| +24% | +$853K | 0.01% | 748 |
|
|
2020
Q2 | $2.52M | Buy |
60,553
+39,045
| +182% | +$1.62M | ﹤0.01% | 787 |
|
|
2020
Q1 | $610K | Buy |
+21,508
| New | +$610K | ﹤0.01% | 963 |
|
|
2019
Q4 | – | Sell |
-1,239
| Closed | -$177K | – | 1336 |
|
|
2019
Q3 | $177K | Buy |
1,239
+402
| +48% | +$57.4K | ﹤0.01% | 1157 |
|
|
2019
Q2 | $153K | Sell |
837
-1,183
| -59% | -$216K | ﹤0.01% | 1103 |
|
|
2019
Q1 | $321K | Sell |
2,020
-630
| -24% | -$100K | ﹤0.01% | 1038 |
|
|
2018
Q4 | $254 | Sell |
2,650
-151
| -5% | -$14 | ﹤0.01% | 1065 |
|
|
2018
Q3 | $396K | Buy |
2,801
+426
| +18% | +$60.2K | ﹤0.01% | 1052 |
|
|
2018
Q2 | $361K | Buy |
+2,375
| New | +$361K | ﹤0.01% | 1093 |
|